4D Molecular Therapeutics, Inc. 4 filing

Filed 2026-06-23 · Report date 2026-06-22 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001834021-26-000002
Form type: 4
CIK: 0001650648
Primary document: https://www.sec.gov/Archives/edgar/data/1650648/000183402126000002/xslF345X06/ownership.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for 4D Molecular Therapeutics, Inc..

Reported financial metrics

Metric	Current	Prior	Change